Paclitaxel: all 2,138 studies that test it

Page 21 of 22. Open to participants first (342), then studies with results posted, then the rest; newest registration first within each.

• Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or LymphomaCompletedNCT00005021Phase 1
• Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid TumorsCompletedNCT00004979Phase 1/2
• Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal CancerCompletedNCT00004934Phase 3
• Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung CancerCompletedNCT00004924Phase 2
• Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's LymphomaCompletedNCT00004916Phase 1/2
• Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During SurgeryStatus unknownNCT00004887Phase 3
• Paclitaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid TumorsCompletedNCT00004863Phase 1
• Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung CancerStatus unknownNCT00004265Phase 2
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer That Cannot Be Removed By SurgeryStatus unknownNCT00004253Phase 2
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian CancerTerminatedNCT00004221Phase 2
• Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung CancerCompletedNCT00004202Phase 2
• Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast CancerCompletedNCT00004174Phase 1
• Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable CancerStatus unknownNCT00004173Phase 1
• Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid TumorTerminatedNCT00004159Phase 1/2
• S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung CancerCompletedNCT00004137Phase 2
• Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung CancerCompletedNCT00004126Phase 2
• Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph NodesCompletedNCT00004125Phase 3
• Combination Chemotherapy in Treating Patients With Advanced CancerCompletedNCT00004105Phase 1/2
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck CancerStatus unknownNCT00004097Phase 1
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or LarynxStatus unknownNCT00004094Phase 2
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung CancerTerminatedNCT00004093Phase 1/2
• Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular CancerCompletedNCT00004077Phase 2
• Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
• Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or LymphomasCompletedNCT00004057Phase 1
• Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung CancerCompletedNCT00004055Phase 2
• Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast CancerCompletedNCT00004013Phase 2
• S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung CancerCompletedNCT00004011Phase 3
• Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial CancerCompletedNCT00003998Phase 3
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00003944Phase 2
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.CompletedNCT00003943Phase 2
• Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung CancerCompletedNCT00003881Phase 2
• Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal CancerTerminatedNCT00003880Phase 2/3
• Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00003812Phase 2
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00003742Phase 1
• Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian CancerStatus unknownNCT00003733Phase 2
• Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian CancerCompletedNCT00003732Phase 2
• Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate CancerStatus unknownNCT00003717Phase 2
• Combination Chemotherapy in Treating Patients With Bladder CancerCompletedNCT00003701Phase 3
• Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial CancerCompletedNCT00003691Phase 3
• Combination Chemotherapy in Treating Men With Germ Cell CancerStatus unknownNCT00003643Phase 2/3
• Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial CancerTerminatedNCT00003624Phase 2
• Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone TherapyWithdrawnNCT00003622Phase 2
• Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate CancerCompletedNCT00003614Phase 2
• Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast CancerCompletedNCT00003612Phase 2
• Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck CancerCompletedNCT00003592Phase 3
• Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic CancerCompletedNCT00003591Phase 2
• S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00003587Phase 2
• Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck CancerCompletedNCT00003582Phase 1/2
• Chemotherapy in Treating Patients With Cancer of Unknown Primary OriginStatus unknownNCT00003558Phase 3
• Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With Recurrent or Refractory Solid TumorsCompletedNCT00003555Phase 1
• Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast CancerCompletedNCT00003539Phase 2
• Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell TumorsCompletedNCT00003518Phase 2
• Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian CancerCompletedNCT00003449Phase 2
• Combination Chemotherapy in Treating Patients With Advanced Prostate CancerCompletedNCT00003394Phase 1/2
• Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During SurgeryCompletedNCT00003387Phase 3
• Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube CancerCompletedNCT00003385Phase 1
• Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical CancerCompletedNCT00003379Phase 1/2
• Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal CancerTerminatedNCT00003378Phase 1
• Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the UrotheliumCompletedNCT00003376Phase 3
• Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's SarcomaCompletedNCT00003350Phase 3
• Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney CancerCompletedNCT00003342Phase 1
• Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive TractCompletedNCT00003334Phase 2
• Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck CancerStatus unknownNCT00003327Phase 2
• Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the EsophagusStatus unknownNCT00003326Phase 2
• Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian CancerCompletedNCT00003322Phase 3
• Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00003299Phase 3
• Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic CancerCompletedNCT00003294Phase 1
• High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung CancerStatus unknownNCT00003284Phase 2
• Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung CancerCompletedNCT00003281Phase 2
• Evaluation of Drug Resistance in Patients With Metastatic Breast CancerStatus unknownNCT00003253Phase 2
• Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck CancerStatus unknownNCT00003251Phase 1/2
• Bryostatin 1 Plus Paclitaxel and Cisplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00003242Phase 1
• Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or StomachCompletedNCT00003237Phase 2
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically RemovedCompletedNCT00003235Phase 3
• Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous LeukemiaCompletedNCT00003230Phase 1/2
• Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal CancerCompletedNCT00003206Phase 2
• Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00003193Phase 1/2
• Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and PlatinumStatus unknownNCT00003160Phase 2
• S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung CancerCompletedNCT00003158Phase 2
• Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder CancerCompletedNCT00003133Phase 1
• Paclitaxel in Treating Women With Recurrent Solid TumorsCompletedNCT00003130Phase 2
• Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the UterusCompletedNCT00003128Phase 3
• S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial CancerCompletedNCT00003127Phase 2
• S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in RemissionCompletedNCT00003120Phase 3
• Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder CancerCompletedNCT00003105Phase 1/2
• Paclitaxel in Treating Older Patients With Solid TumorsCompletedNCT00003092Phase 3
• Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung CancerCompletedNCT00003089Phase 2
• Combination Chemotherapy in Treating Patients With Breast CancerCompletedNCT00003088Phase 3
• Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the EsophagusCompletedNCT00003087Phase 2
• Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate CancerCompletedNCT00003084Phase 2
• Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung CancerCompletedNCT00003072Phase 2
• Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the CervixCompletedNCT00003065Phase 2
• Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the UterusTerminatedNCT00003054Phase 2
• Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast CancerCompletedNCT00003050Phase 2
• Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast CancerCompletedNCT00003035Phase 2
• Chemotherapy Plus Surgery in Treating Women With Breast CancerCompletedNCT00003013Phase 3
• Paclitaxel in Treating Patients With AIDS-Related Kaposi's SarcomaCompletedNCT00003008Phase 2
• Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid TumorsCompletedNCT00003004Phase 1
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the EsophagusCompletedNCT00002984Phase 1/2
• Paclitaxel in Treating Patients With Lung CancerCompletedNCT00002972Phase 2

← Paclitaxel overview